According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM ) is NZ$6.32 Billion. In 2023 the company made a revenue of NZ$5.27 Billion an increase over the revenue in the year 2022 that were of NZ$4.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.